APLS

NASDAQStock

Apellis Pharmaceuticals, Inc.

$18.69+0.30 (+1.63%)

52-Week Range

$16.36
$30.05

Key Stats

Market Cap

2.4B

P/E Ratio

60.29

Dividend Yield

Beta

0.29

Volume

785.7K

Avg Volume

2.0M

Performance

1M

-16.60%

3M

-25.12%

6M

-24.60%

YTD

-28.89%

1Y

-25.43%

3Y

-71.94%

5Y

-60.96%

Price Chart

ETF Exposure

APLS is held by 133 ETFs

ETFFund NameWeight
JFWDJacob Forward ETF2.59%
SBIOALPS Medical Breakthroughs ETF1.54%
FXHFirst Trust Health Care AlphaDEX Fund1.42%
PINKSimplify Health Care ETF1.36%
PSCHInvesco S&P SmallCap Health Care ETF1.21%
BBPVirtus Biotech ETF1.16%
CURE.AXGlobal X - S&P Biotech ETF0.69%
XBIState Street SPDR S&P Biotech ETF0.69%
MRNDIQ U.S. Mid Cap R&D Leaders ETF0.68%
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETF0.51%
RZGInvesco S&P SmallCap 600 Pure Growth ETF0.42%
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.39%
FVIFirst Trust Total US Market AlphaDEX ETF0.30%
VIOGVanguard S&P Small-Cap 600 Growth ETF0.29%
IJTiShares S&P Small-Cap 600 Growth ETF0.26%
SLYGState Street SPDR S&P 600 Small Cap Growth ETF0.25%
IBBQInvesco Nasdaq Biotechnology ETF0.19%
SBIO.LInvesco NASDAQ Biotech UCITS ETF0.19%
2B77.DEiShares Ageing Population UCITS ETF0.18%
STLGiShares Factors US Growth Style ETF0.18%
IBBiShares Biotechnology ETF0.18%
LABUDirexion Daily S&P Biotech Bull 3X ETF0.15%
VIOOVanguard S&P Small-Cap 600 ETF0.15%
PWSPacer WealthShield ETF0.14%
FYXFirst Trust Small Cap Core AlphaDEX Fund0.14%
IJRiShares Core S&P Small-Cap ETF0.13%
BIBProShares - Ultra Nasdaq Biotechnology0.13%
IDP6.LiShares S&P SmallCap 600 UCITS ETF0.13%
IJR.AXiShares S&P Small-Cap ETF0.13%
IUS3.DEiShares S&P SmallCap 600 UCITS ETF0.13%
XSMC.TOiShares S&P U.S. Small-Cap Index ETF0.13%
XSMH.TOiShares S&P U.S. Small-Cap Index ETF (CAD-Hedged)0.13%
SPSMState Street SPDR Portfolio S&P 600 Small Cap ETF0.13%
RFLRInnovator U.S. Small Cap Managed Floor ETF0.12%
STXKStrive Small-Cap ETF0.10%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.10%
SAAProShares - Ultra SmallCap6000.09%
BBSCJPMorgan BetaBuilders U.S. Small Cap Equity ETF0.09%
BKSEBNY Mellon US Small Cap Core Equity ETF0.09%
FADFirst Trust Multi Cap Growth AlphaDEX Fund0.08%
KBFRInnovator U.S. Small Cap Managed 10 Buffer ETF0.08%
VBKVanguard Small-Cap Growth ETF0.07%
IWPiShares Russell Mid-Cap Growth ETF0.07%
STSBiShares Factors US Small Blend Style ETF0.07%
EESWisdomTree U.S. SmallCap Fund0.07%
EQALInvesco Russell 1000 Equal Weight ETF0.07%
ISCGiShares Morningstar Small-Cap Growth ETF0.06%
JKKiShares Morningstar Small-Cap Growth ETF0.06%
SCHASchwab U.S. Small-Cap ETF0.05%
DFASDimensional - US Small Cap ETF0.04%
Page 1 of 3Next

About APLS ETF Exposure

Apellis Pharmaceuticals, Inc. (APLS) is held by 133 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 2.4B, APLS is a widely held institutional stock. The stock currently trades at $18.69. Investors can gain exposure to APLS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold APLS, sorted by portfolio weight.